Olli Lohi1, Mataleena Parikka, Mika Rämet. 1. Paediatric Research Centre, University of Tampere Medical School and Tampere University Hospital, Tampere, Finland.
Abstract
UNLABELLED: The rapid increase in information about genes and their associations with human diseases has highlighted the need for model organisms suitable for genetic manipulation and drug testing. The zebrafish is a valuable vertebrate animal model that offers many advantages, including the relative ease of husbandry and genetic manipulation and the capacity for high-throughput screens. In this review, we describe the zebrafish as a model for paediatric diseases, with particular emphasis on haematopoietic and infectious diseases. CONCLUSION: The zebrafish has become an established vertebrate model in which to elucidate the molecular mechanisms of various human diseases.
UNLABELLED: The rapid increase in information about genes and their associations with human diseases has highlighted the need for model organisms suitable for genetic manipulation and drug testing. The zebrafish is a valuable vertebrate animal model that offers many advantages, including the relative ease of husbandry and genetic manipulation and the capacity for high-throughput screens. In this review, we describe the zebrafish as a model for paediatric diseases, with particular emphasis on haematopoietic and infectious diseases. CONCLUSION: The zebrafish has become an established vertebrate model in which to elucidate the molecular mechanisms of various human diseases.
Authors: Markus J T Ojanen; Hannu Turpeinen; Zuzet M Cordova; Milka M Hammarén; Sanna-Kaisa E Harjula; Mataleena Parikka; Mika Rämet; Marko Pesu Journal: Infect Immun Date: 2015-01-26 Impact factor: 3.441
Authors: Barbara Taskinen; Joanna Zmurko; Markus Ojanen; Sampo Kukkurainen; Marimuthu Parthiban; Juha A E Määttä; Jenni Leppiniemi; Janne Jänis; Mataleena Parikka; Hannu Turpeinen; Mika Rämet; Marko Pesu; Mark S Johnson; Markku S Kulomaa; Tomi T Airenne; Vesa P Hytönen Journal: PLoS One Date: 2013-10-24 Impact factor: 3.240
Authors: M Javier Herrero-Turrión; Iván Rodríguez-Martín; Roger López-Bellido; Raquel E Rodríguez Journal: BMC Genomics Date: 2014-10-08 Impact factor: 3.969
Authors: Ashok Aspatwar; Martti E E Tolvanen; Markus J T Ojanen; Harlan R Barker; Anni K Saralahti; Carina A Bäuerlein; Csaba Ortutay; Peiwen Pan; Marianne Kuuslahti; Mataleena Parikka; Mika Rämet; Seppo Parkkila Journal: PLoS One Date: 2015-07-28 Impact factor: 3.240